Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 CAD | -.--% | -.--% | -.--% |
Business Summary
Sales per Business
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Diagnosis and Treatment of Neurological Diseases and Disorders
100.0
%
| 4 | 100.0 % | 0 | 100.0 % | -99.07% |
Sales per region
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 4 | 100.0 % | 0 | 100.0 % | -99.07% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Deborah Rathjen
CEO | Chief Executive Officer | - | 17-09-20 |
Dave Jenkins
DFI | Director of Finance/CFO | - | 21-06-30 |
Mei Mei Tian
CTO | Chief Tech/Sci/R&D Officer | - | 11-12-31 |
Graeme Dick
IRC | Investor Relations Contact | - | 11-10-31 |
Christopher Lowe
SEC | Corporate Secretary | 56 | 17-10-02 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Hemeon
BRD | Director/Board Member | 59 | - |
David Wurzer
BRD | Director/Board Member | 65 | 18-07-26 |
Deborah Rathjen
CEO | Chief Executive Officer | - | 17-09-20 |
Director/Board Member | 63 | 18-05-31 | |
John E. Curran
BRD | Director/Board Member | - | 18-07-26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 79,414,015 | 77,784,778 ( 97.95 %) | 0 | 97.95 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-.--% | 290K | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- BTI Stock
- Company Bioasis Technologies Inc.